Suppr超能文献

出生后口服益生菌大肠杆菌可降低日后生活中(10年和20年后)过敏和反复感染的发生率。

Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years).

作者信息

Lodinová-Zádníková Rája, Cukrowska Bozena, Tlaskalova-Hogenova Helena

机构信息

Institute for Care of Mother and Child, Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

出版信息

Int Arch Allergy Immunol. 2003 Jul;131(3):209-11. doi: 10.1159/000071488.

Abstract

BACKGROUND

The development of allergies is a complex in which both composition and influence of the intestinal flora play an important role. We observed in earlier studies that the presence of an orally administered probiotic Escherichia coli strain in the intestine stimulated both a serum and local antibody response, decreased the presence of pathogens, the number of infections and the need for antibiotics.

METHODS

The preventive effect of oral colonization after birth with a probiotic E. COLI strain was assessed by evaluating the results of a questionnaire both 20 years (150 full-term infants) and 10 years (77 preterm infants) after colonization.

RESULTS

Differences in occurrence of allergies in colonized and control subjects were statistically significant both after 10 and 20 years (p < 0.01). Specific serum IgE antibodies confirmed the presence of allergies in 100% of 10-year-old and 91% of 20-year-old patients with clinical symptoms of allergy. Ten years after colonization, the occurrence of repeated infections was significantly lower in colonized subjects than it was in controls (p < 0.01); 20 years later, no differences were found in these groups.

CONCLUSIONS

Intentional colonization of the intestine with E. coli after birth (offering the advantage of the first colonizer) was found to decrease the incidence of allergies and repeated infections in later life.

摘要

背景

过敏的发生是一个复杂过程,其中肠道菌群的组成和影响都起着重要作用。我们在早期研究中观察到,肠道中口服益生菌大肠杆菌菌株的存在会刺激血清和局部抗体反应,减少病原体的存在、感染次数以及对抗生素的需求。

方法

通过评估定植后20年(150名足月儿)和10年(77名早产儿)的问卷调查结果,评估出生后口服益生菌大肠杆菌菌株进行肠道定植的预防效果。

结果

定植组和对照组在10年和20年后过敏发生率的差异具有统计学意义(p < 0.01)。特异性血清IgE抗体证实,100%有过敏临床症状的10岁患者和91%的20岁患者存在过敏。定植10年后,定植组反复感染的发生率显著低于对照组(p < 0.01);20年后,这些组之间未发现差异。

结论

出生后有意用大肠杆菌进行肠道定植(具有首批定植菌的优势)可降低日后生活中过敏和反复感染的发生率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验